Yannis M Paulus, MD

Yannis M Paulus, MD

Johns Hopkins University, Wilmer Eye Institute
600 N Wolfe St, Baltimore, MD
Baltimore, MD 21287
United States map
https://www.hopkinsmedicine.org/wilmer/research/retina/paulus-lab

Wilmer Eye Institute at Columbia
Medical Pavilion at Howard County
10710 Charter Dr Suite 310
Columbia, MD 21044
United States map

(410) 955-5080 office


Professional Affiliations

Academic Appointments
  • Dr. Jonas Friedenwald Professor in Ophthalmology
  • Associate Professor, Department of Ophthalmology
  • Associate Professor, Department of Biomedical Engineering
  • Wilmer Eye Institute
  • Johns Hopkins University
Hospital Appointments
  • Johns Hopkins Hospital

Education and Training

Retinal fellowship
Johns Hopkins Medical Institutions, Johns Hopkins School of Medicine, Baltimore, MD USA
Ophthalmology residency
Stanford University, Department of Ophthalmology, Palo Alto, CA USA
Internship
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Medical School
Stanford University School of Medicine, Stanford, CA USA
College
Harvard University, Cambridge, MA USA

Biography

I am an academic vitreoretinal surgeon and clinician scientist that loves applying biomedical engineering, photonics, optics, and lasers to develop novel retinal imaging and laser systems. I am
the Dr. Jonas Friedenwald Professor in Ophthalmology, Associate Professor, Department of Ophthalmology, Associate Professor, Department of Biomedical Engineering, at the Wilmer Eye Institute, Johns Hopkins University. I completed my undergraduate in chemistry and physics at Harvard University, medical school and ophthalmology residency at Stanford University, transitional internship at Memorial Sloan-Kettering Cancer Center, and surgical and medical retina fellowship at Johns Hopkins University Wilmer Eye Institute. I direct an active, multidisciplinary laboratory dedicated to improving the vision of patients suffering from eye diseases by developing novel minimally traumatic retinal laser therapies, photoacoustic and molecular imaging of the retina for retinal and choroidal neovascularization, and novel, inexpensive retinal imaging systems. We seek to improve early disease diagnosis, improve treatment monitoring, and practice more individualized precision medicine tailored to each patient through molecular imaging. We have developed a novel, multimodal molecular imaging system to visualize individual capillaries and neovascularization of the eye using a safe energy level that incorporates photoacoustic microscopy, optical coherence tomography, and confocal fluorescence microscopy. We also are developing a novel new treatment using a combination of nanosecond pulse duration laser with ultrasound to selectively treat blood vessels called photo-mediated ultrasound therapy.

I have received several entrepreneurship awards and patents, published more than 150 peer-reviewed publications and 10 book chapters, and consulted for several medical device and start-up companies. I have co-developed a novel, inexpensive system for providing tele-ultrasound, founded imaging companies, and investigate pattern scanning laser photocoagulation, laser-tissue interactions, and restorative retinal laser therapy to create minimally traumatic retinal laser therapy. I serve on the editorial board of 5 journals and have reviewed articles for more than 60 journals. I have received numerous fellowships and awards from the Heed Ophthalmic Foundation, the Evangelos S. Gragoudas Award from the Macula Society, Starr E. Shulman MPA Fellow by the California Academy of Eye Physicians & Surgeons, ISER fellowship, ASCRS Foundation, International Society for Eye Research (ISER) Travel Fellowship, National Eye Institute Travel Grant, and AUPO/RPB. I was recognized as Greek America’s Forty Under Forty and served as President of the Hellenic American Professional Society of Northern California.